Physician profile
John A Rialson
NPI 1649502436
$10,326.96
in general payments reported to CMS, 2019-2025
20 companies · $2,486 in 2025
The $2,486 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $249 · 2021: $1,151 · 2022: $1,521 · 2023: $836 · 2024: $3,424 · 2025: $2,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,719 · Food and Beverage: $2,562 · Travel and Lodging: $1,425 · Education: $39.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,718.75 |
| Food and Beverage | $2,562.01 |
| Travel and Lodging | $1,424.93 |
| Education | $39.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $4,465.82 | 2019-2024 | Portfolio, Grappler, Mister Tendon |
| Treace Medical Concepts, INC. | $1,892.49 | 2022-2025 | |
| Restor3d, INC. | $1,866.31 | 2025 | |
| Stryker Corporation | $251.47 | 2022-2024 | Citrefix, Phalinx, Metal Hemi |
| Organogenesis INC. | $237.70 | 2019-2025 | Cygnus Dual |
| Horizon Therapeutics Plc | $213.90 | 2019-2022 | |
| Integra Lifesciences Corporation | $211.12 | 2019 | |
| Kerecis Limited | $192.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $142.15 | 2024-2025 | |
| Wright Medical Technology, INC. | $124.25 | 2019 | |
| Biopoly LLC | $116.85 | 2023 | |
| Lightbody Medical Technologies INC | $116.70 | 2024 | |
| Osteomed LLC | $114.94 | 2020 | |
| Microaire Surgical Instruments LLC | $93.22 | 2022 | |
| Depuy Synthes Sales INC. | $86.06 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65.19 | 2025 | |
| Abbott Laboratories | $58.92 | 2025 | Esprit |
| Acumed LLC | $53.85 | 2019-2023 | Innate Implant, Inframe Implant |
| Arteriocyte Medical Systems, INC. | $12.53 | 2019 | |
| Embody, INC. | $11.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rialson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.